Universal nirsevimab prophylaxis is linked to fewer respiratory syncytial virus cases and milder disease in infants, real-world evidence from Italy shows.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/universal-nirsevimab-linked-lower-rsv-burden-infants-2026a10002bb?src=rss
Author :
Publish date : 2026-01-28 12:00:00
Copyright for syndicated content belongs to the linked Source.